Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis

ClinicalTrials.gov ID: NCT04800315

Public ClinicalTrials.gov record NCT04800315. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 7:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Global, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Cendakimab (CC-93538) in Adult Subjects With Moderate to Severe Atopic Dermatitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the effectiveness and safety of 3 dose regimen of CC-93538 in adult participants with moderate to severe Atopic Dermatitis (AD).

Study identification

NCT ID
NCT04800315
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Celgene
Industry
Enrollment
221 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 13, 2021
Primary completion
Jul 19, 2022
Completion
Nov 8, 2022
Last update posted
Jan 2, 2024

2021 – 2022

United States locations

U.S. sites
62
U.S. states
21
U.S. cities
31
Facility City State ZIP Site status
Clinical Research Center of Alabama Birmingham Alabama 35209
Local Institution - 119 Birmingham Alabama 35209
Cahaba Dermatology Birmingham Alabama 35244
Local Institution - 114 Birmingham Alabama 35244
Burke Pharmaceutical Research Hot Springs Arkansas 71913-6440
Local Institution - 129 Hot Springs Arkansas 71913-6440
First OC Dermatology Fountain Valley California 92708
Local Institution - 105 Fountain Valley California 92708
George Washington University School of Medicine and Health Sciences Washington D.C. District of Columbia 20037-3201
Local Institution - 128 Washington D.C. District of Columbia 20037-3201
Total Vein and Skin, LLC Boynton Beach Florida 33437
Local Institution - 106 Delray Beach Florida 33484-6500
Palm Beach Dermatology Group Delray Beach Florida 33484-6500
GCP Global Clinical Professionals St. Petersburg Florida 33702
Local Institution - 135 St. Petersburg Florida 33702
ForCare Clinical Research Tampa Florida 33624-2038
Local Institution - 101 Tampa Florida 33624-2038
Local Institution - 103 West Palm Beach Florida 33401-3430
Metabolic Research Institute Inc West Palm Beach Florida 33401-3430
Aeroallergy Research Labs of Savannah Savannah Georgia 31406-2668
Local Institution - 134 Savannah Georgia 31406-2668
Local Institution - 108 Springfield Illinois 62702-5115
Sneeze Wheeze and Itch Associates LLC Springfield Illinois 62702-5115
DS Research Clarksville Indiana 47129-2201
Local Institution - 115 Clarksville Indiana 47129-2201
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46256
Local Institution - 110 Indianapolis Indiana 46256
Local Institution - 107 West Lafayette Indiana 47906-1569
Randall Dermatology West Lafayette Indiana 47906-1569
Local Institution - 138 Westfield Indiana 46074
Randall Dermatology - Westfield Campus Westfield Indiana 46074
Kansas City Dermatology P.A. Overland Park Kansas 66215-2377
Local Institution - 116 Overland Park Kansas 66215-2377
DS Research Louisville Kentucky 40241
Local Institution - 117 Louisville Kentucky 40241
DermAssociates Silver Spring Maryland 20902-5006
Local Institution - 125 Silver Spring Maryland 20902-5006
Local Institution - 133 Clarkston Michigan 48346
Skin Research Clarkston/Clarkston Dermatology Clarkston Michigan 48346
Local Institution - 137 Omaha Nebraska 68144
Skin Specialists PC Omaha Nebraska 68144
JDR Dermatology Research, LLC Las Vegas Nevada 89148
Local Institution - 121 Las Vegas Nevada 89148
Local Institution - 112 Hackensack New Jersey 07601-1974
Skin Laser and Surgery Specialists of New York and New Jersey LLC Hackensack New Jersey 07601-1974
Icahn School of Medicine at Mount Sinai Great Neck New York 11021-5506
Local Institution - 130 Great Neck New York 11021-5506
Local Institution - 126 New York New York 10075
Sadick Research Group New York New York 10075
Central Sooner Research Norman Oklahoma 73069-6301
Local Institution - 111 Norman Oklahoma 73069-6301
Local Institution - 127 Tulsa Oklahoma 74136-8303
Vital Prospects Clinical Research Institute PC - CRN - PPDS Tulsa Oklahoma 74136-8303
Local Institution - 109 Portland Oregon 97223
Oregon Medical Research Center, P.C. Portland Oregon 97223
Clinical Partners, LLC Johnston Rhode Island 02919
Local Institution - 123 Johnston Rhode Island 02919
International Clinical Research Murfreesboro Tennessee 37130
Local Institution - 100 Murfreesboro Tennessee 37130
Clinical Research Partners LLC Henrico Virginia 23233-1487
Local Institution - 104 Richmond Virginia 23233-1436
West End Dermatology Associates Richmond Virginia 23233-1436

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 95 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04800315, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 2, 2024 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04800315 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →